SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Companion Diagnostic Technologies Market (Indication and Geography) - Forecast to 2020

[June 27, 2014]

Research and Markets: Global Companion Diagnostic Technologies Market (Indication and Geography) - Forecast to 2020

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/k23w79/global_companion) has announced the addition of the "Global Companion Diagnostic Technologies Market (Indication and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America,Europe, Asia Pacific and LAMEA).


Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market. Opportunities for this market lie in developing companion diagnostics for various central nervous system conditions and hereditary conditions.

Companion Diagnostics Indication Market Analysis

Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.

Key Topics Covered:

CHAPTER 1. INTRODUCTION

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. MARKET OVERVIEW

CHAPTER 4. GLOBAL COMPANION DIAGNOSTIC MARKET BY INDICATIONS

CHAPTER 5. GLOBAL COMPANION DIAGNOSTIC MARKET BY TECHNOLOGY

CHAPTER 6. GLOBAL COMPANION DIAGNOSTICS BY GEOGRAPHY

CHAPTER 7. COMPANY PROFILES

Companies Mentioned:

  • Abbott Laboratories
  • bioMerieux
  • Dako (Agilent (News - Alert) Technologies)
  • Leica Microsystems
  • Life Technologies
  • Myriad Genetics
  • Qiagen
  • Resonance Health Ltd
  • Roche
  • Ventana Medical Systems

For more information visit http://www.researchandmarkets.com/research/k23w79/global_companion


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy